{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:25:01Z","timestamp":1761989101219,"version":"3.44.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01HL071138-08"],"award-info":[{"award-number":["5R01HL071138-08"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15GRNT25700451"],"award-info":[{"award-number":["15GRNT25700451"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ejphar.2017.08.024","type":"journal-article","created":{"date-parts":[[2017,8,20]],"date-time":"2017-08-20T02:15:18Z","timestamp":1503195318000},"page":"294-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta"],"prefix":"10.1016","volume":"814","author":[{"given":"Brandi M.","family":"Wynne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hicham","family":"Labazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zidonia N.","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita C.","family":"Tostes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Clinton","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2017.08.024_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1476-5381.2009.00150.x","article-title":"A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries","volume":"157","author":"Andrews","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/CS20140759","article-title":"Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance","volume":"129","author":"Andrews","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2017.08.024_bib3","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1073\/pnas.041481598","article-title":"On the acidity and reactivity of HNO in aqueous solution and biological systems","volume":"98","author":"Bartberger","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2017.08.024_bib4","first-page":"4793","article-title":"Role of short-acting nitroglycerin in the management of ischemic heart disease","volume":"9","author":"Boden","year":"2015","journal-title":"Drug Des. Dev. Therapy"},{"key":"10.1016\/j.ejphar.2017.08.024_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-0035-1548765","article-title":"Oxidative stress in hypertension: mechanisms and therapeutic opportunities","volume":"123","author":"Brito","year":"2015","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.ejphar.2017.08.024_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.yjmcc.2013.10.013","article-title":"Angiotensin II induces Fat1 expression\/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation","volume":"66","author":"Bruder-Nascimento","year":"2014","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/cvr\/cvp304","article-title":"Thyroid hormone stimulates NO production via activation of the PI3K\/Akt pathway in vascular myocytes","volume":"85","author":"Carrillo-Sepulveda","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2017.08.024_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.phrs.2015.12.006","article-title":"The HNO donor Angeli's salt offers potential haemodynamic advantages over NO or dobutamine in ischaemia-reperfusion injury in the rat heart ex vivo","volume":"104","author":"Chin","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2017.08.024_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1734-1140(09)70005-2","article-title":"Nitrate tolerance as a model of vascular dysfunction: roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress","volume":"61","author":"Daiber","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2017.08.024_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/107424849800300107","article-title":"Formation of reactive oxygen species in various vascular cells during glyceryltrinitrate metabolism","volume":"3","author":"Dikalov","year":"1998","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2017.08.024_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cardiores.2006.11.018","article-title":"The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature","volume":"73","author":"Favaloro","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2017.08.024_bib12","doi-asserted-by":"crossref","first-page":"H1274","DOI":"10.1152\/ajpheart.00008.2009","article-title":"Redox variants of NO (NO{middle dot} and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms","volume":"296","author":"Favaloro","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib13","doi-asserted-by":"crossref","first-page":"H2377","DOI":"10.1152\/ajpheart.00429.2001","article-title":"Diminished arteriolar responses in nitrate tolerance involve ROS and angiotensin II","volume":"282","author":"Frame","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib14","doi-asserted-by":"crossref","first-page":"H790","DOI":"10.1152\/ajpheart.01141.2006","article-title":"Possible usefulness of apocynin, an NADPH oxidase inhibitor, for nitrate tolerance: prevention of NO donor-induced endothelial cell abnormalities","volume":"293","author":"Fukatsu","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/tx0496800","article-title":"The physiological chemistry and biological activity of nitroxyl (HNO): the neglected, misunderstood, and enigmatic nitrogen oxide","volume":"18","author":"Fukuto","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.pharmtox.45.120403.095959","article-title":"Nitroxyl (HNO): chemistry, biochemistry, and pharmacology","volume":"45","author":"Fukuto","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4330\/wjc.v6.i6.353","article-title":"Essential hypertension and oxidative stress: new insights","volume":"6","author":"Gonzalez","year":"2014","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib18","first-page":"1003","article-title":"A pulse radiolytic sutdy of short-lived byproducts on nitric oxide reduction in aqueous solution","volume":"74","author":"Gratzel","year":"1970","journal-title":"Ber. Bunsenges. Phys. Chem."},{"key":"10.1016\/j.ejphar.2017.08.024_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ajh\/hpw078","article-title":"Endothelin-1 overexpression exaggerates diabetes-induced endothelial dysfunction by altering oxidative stress","author":"Idris-Khodja","year":"2016","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2017.08.024_bib20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(14)61121-1","article-title":"Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial","volume":"385","author":"Investigators","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2017.08.024_bib21","article-title":"Chronic administration of the HNO donor, Angeli's salt does not lead to tolerance, cross-tolerance or endothelial dysfunction: comparison with GTN and DEA\/NO","author":"Irvine","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejphar.2017.08.024_bib22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/01.HYP.0000072010.54901.DE","article-title":"NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries","volume":"41","author":"Irvine","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2017.08.024_bib23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/01.HYP.0000259328.04159.90","article-title":"Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae","volume":"49","author":"Irvine","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2017.08.024_bib24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.tips.2008.08.005","article-title":"Nitroxyl (HNO): the Cinderella of the nitric oxide story","volume":"29","author":"Irvine","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2017.08.024_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/157488409788185016","article-title":"Long-term use of short- and long-acting nitrates in stable angina pectoris","volume":"4","author":"Kosmicki","year":"2009","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/STROKEAHA.115.010368","article-title":"Glyceryl trinitrate for acute intracerebral hemorrhage: results from the efficacy of nitric oxide in stroke (ENOS) trial, a subgroup analysis","volume":"47","author":"Krishnan","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2017.08.024_bib27","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/bph.13467","article-title":"Endothelin-1 shifts the mediator of bradykinin-induced relaxation from NO to H2O2 in resistance arteries from patients with cardiovascular disease","volume":"173","author":"Leurgans","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.taap.2003.12.007","article-title":"Peroxynitrite-induced relaxation in isolated canine cerebral arteries and mechanisms of action","volume":"196","author":"Li","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib29","doi-asserted-by":"crossref","first-page":"H1042","DOI":"10.1152\/ajpheart.00800.2006","article-title":"Peroxynitrite diminishes myogenic tone in cerebral arteries: role of nitrotyrosine and F-actin","volume":"292","author":"Maneen","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib30","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/01.STR.0000204043.18592.0d","article-title":"Peroxynitrite diminishes myogenic activity and is associated with decreased vascular smooth muscle F-actin in rat posterior cerebral arteries","volume":"37","author":"Maneen","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2017.08.024_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1476-5381.2009.00153.x","article-title":"Nitroxyl anion\u2013the universal signalling partner of endogenously produced nitric oxide?","volume":"157","author":"Martin","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2016.04.006","article-title":"Recent advances in the chemical biology of nitroxyl (HNO) detection and generation","volume":"57","author":"Miao","year":"2016","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejphar.2017.08.024_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MNH.0000000000000153","article-title":"Redox signaling, Nox5 and vascular remodeling in hypertension","volume":"24","author":"Montezano","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ejphar.2017.08.024_bib34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/01.RES.0000184694.03262.6d","article-title":"Explaining the phenomenon of nitrate tolerance","volume":"97","author":"Munzel","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2017.08.024_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1172\/JCI117637","article-title":"Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance","volume":"95","author":"Munzel T","year":"1995","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2017.08.024_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.vph.2014.09.002","article-title":"Organic nitrates: update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction","volume":"63","author":"Munzel","year":"2014","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0140-6736(02)46032-1","article-title":"Nitroglycerin as a remedy for angina pectoris","volume":"1","author":"Murrell","year":"1879","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2017.08.024_bib38","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1089\/ars.2012.4641","article-title":"Angiotensin II, NADPH oxidase, and redox signaling in the vasculature","volume":"19","author":"Nguyen Dinh Cat","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejphar.2017.08.024_bib39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/HYPERTENSIONAHA.109.135426","article-title":"Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and Angiotensin blockade","volume":"55","author":"Palm","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2017.08.024_bib40","doi-asserted-by":"crossref","first-page":"H1217","DOI":"10.1152\/ajpheart.00243.2009","article-title":"The shy Angeli and his elusive creature: the HNO route to vasodilation","volume":"296","author":"Paolocci","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tice.2005.12.004","article-title":"Resting smooth muscle cells as a model for studying vascular cell activation","volume":"38","author":"Poliseno","year":"2006","journal-title":"Tissue Cell"},{"key":"10.1016\/j.ejphar.2017.08.024_bib42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000329054","article-title":"Endothelin, nitric oxide, and reactive oxygen species in diabetic kidney disease","volume":"172","author":"Pollock","year":"2011","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/hr.2010.264","article-title":"The role of oxidative stress in the pathophysiology of hypertension","volume":"34","author":"Rodrigo","year":"2011","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2017.08.024_bib44","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1161\/01.CIR.102.23.2810","article-title":"Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion","volume":"102","author":"Sage","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2017.08.024_bib45","first-page":"152","article-title":"Inflammation in hypertension","volume":"15","author":"Savoia","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ejphar.2017.08.024_bib46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20060247","article-title":"Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions","volume":"112","author":"Savoia","year":"2007","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2017.08.024_bib47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jash.2006.11.003","article-title":"The vascular phenotypes in hypertension: relation with the natural history of hypertension","volume":"1","author":"Schiffrin","year":"2007","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.ejphar.2017.08.024_bib48","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/hc1002.105186","article-title":"Functional and biochemical analysis of endothelial (dys)function and NO\/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment","volume":"105","author":"Schulz","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2017.08.024_bib49","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1073\/pnas.112202099","article-title":"Nitroxyl and its anion in aqueous solutions: spin states, protic equilibria, and reactivities toward oxygen and nitric oxide","volume":"99","author":"Shafirovich","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2017.08.024_bib50","doi-asserted-by":"crossref","first-page":"4867124","DOI":"10.1155\/2016\/4867124","article-title":"Nitroxyl (HNO): a reduced form of nitric oxide with distinct chemical, pharmacological, and therapeutic properties","volume":"2016","author":"Shoman","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.ejphar.2017.08.024_bib51","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1042\/CS20140758","article-title":"Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus","volume":"129","author":"Silva","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2017.08.024_bib52","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.bbabio.2009.04.015","article-title":"The emergence of nitroxyl (HNO) as a pharmacological agent","volume":"1787","author":"Switzer","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2017.08.024_bib53","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.pharep.2015.04.009","article-title":"Mitochondrial mechanisms of endothelial dysfunction","volume":"67","author":"Szewczyk","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2017.08.024_bib54","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.yjmcc.2007.03.904","article-title":"Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation","volume":"42","author":"Szocs","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2017.08.024_bib55","doi-asserted-by":"crossref","first-page":"12383","DOI":"10.1073\/pnas.91.26.12383","article-title":"Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart","volume":"91","author":"Villa","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2017.08.024_bib56","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11906-002-0041-2","article-title":"Reactive oxygen species: roles in blood pressure and kidney function","volume":"4","author":"Wilcox","year":"2002","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.ejphar.2017.08.024_bib57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.01.003","article-title":"Effects of tempol and redox-cycling nitroxides in models of oxidative stress","volume":"126","author":"Wilcox","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2017.08.024_bib58","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1161\/STROKEAHA.115.009647","article-title":"Effect of hyperacute administration (within 6h) of transdermal glyceryl trinitrate, a nitric oxide donor, on outcome after stroke: subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trial","volume":"46","author":"Woodhouse","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2017.08.024_bib59","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jash.2008.09.002","article-title":"Vascular smooth muscle cell signaling mechanisms for contraction to angiotensin II and endothelin-1","volume":"3","author":"Wynne","year":"2009","journal-title":"J. Am. Soc. Hypertens."},{"key":"10.1016\/j.ejphar.2017.08.024_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phrs.2011.07.002","article-title":"Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses","volume":"65","author":"Wynne","year":"2012","journal-title":"Pharmacol. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991730537X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991730537X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:22:05Z","timestamp":1757974925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991730537X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":60,"alternative-id":["S001429991730537X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.08.024","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}